Protara Therapeutics, Inc. (TARA)
3.905
+0.04
(+1.17%)
USD |
NASDAQ |
Sep 01, 16:00
3.905
0.00 (0.00%)
After-Hours: 19:49
Protara Therapeutics Total Long Term Debt (Quarterly) : 1.463M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.463M |
| March 31, 2026 | 1.793M |
| December 31, 2025 | 2.117M |
| September 30, 2025 | 2.436M |
| June 30, 2025 | 2.749M |
| March 31, 2025 | 3.057M |
| December 31, 2024 | 3.359M |
| September 30, 2024 | 3.657M |
| June 30, 2024 | 3.949M |
| March 31, 2024 | 4.227M |
| December 31, 2023 | 4.484M |
| September 30, 2023 | 4.736M |
| June 30, 2023 | 4.984M |
| March 31, 2023 | 5.227M |
| December 31, 2022 | 5.467M |
| September 30, 2022 | 5.702M |
| June 30, 2022 | 5.933M |
| March 31, 2022 | 6.16M |
| December 31, 2021 | 6.384M |
| September 30, 2021 | 6.603M |
| June 30, 2021 | 6.819M |
| March 31, 2021 | 0.974M |
| December 31, 2020 | 0.999M |
| September 30, 2020 | 0.3947M |
| June 30, 2020 | 0.3789M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.3865M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 4.338M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| NovelStem International Corp. | 1.620M |
| Brainstorm Cell Therapeutics, Inc. | 0.00 |
| Summit Therapeutics, Inc. | 16.83M |
| Kezar Life Sciences, Inc. | 0.00 |
| Clene, Inc. | 21.53M |